Data collected from the U.S. Centers for Disease Control and Prevention’s V-safe app reveal that women and also recipients of the Moderna and Johnson & Johnson COVID-19 vaccines were disproportionately affected by adverse events following their vaccination.
Data collected from the Centers for Disease Control and Prevention’s (CDC) V-safe app reveal that women and also recipients of the Moderna and Johnson & Johnson (J&J) COVID-19 vaccines were disproportionately affected by adverse events following their vaccination.
The data were publicized Oct. 3 by the Austin-based nonprofit Informed Consent Action Network (ICAN) following its successful lawsuit against the CDC and a court order demanding the CDC release the data.
ICAN published the data using a graphical online dashboard and also made the raw data — containing more than 144 million lines of health data — available to the public.
The V-safe smartphone app collected post-vaccination health assessments from approximately 10 million people between Dec. 14, 2020, and July 31, 2022.
Del Bigtree, CEO of ICAN, described the data file as “huge, gigantic” and remarked on the CDC’s failure to make this information available.
“The CDC had billions of dollars to build something like this,” he said. “They didn’t do it, so we did it for them.”
Newly obtained emails shed more light on the Centers for Disease Control and Prevention’s false COVID-19 vaccine safety monitoring statements.https://t.co/M5dd4SGpoN
— Robert F. Kennedy Jr (@RobertKennedyJr) October 4, 2022
Adverse events for Moderna, J&J recipients disproportionately high
According to data presented by Statista, of the more than 610 million COVID-19 vaccines administered in the U.S. as of Sept. 7, 59.2% (361.3 million) were Pfizer, 37.6% (229.8 million) were Moderna and 3.1% (18.9 million) were J&J.
However, the V-safe data reveal that out of the 3.35 million people who reported being affected in some way by the vaccines, 48.3% received the Moderna vaccine and 4.7% received the J&J vaccine.
